- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/14 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
Patent holdings for IPC class C07D 217/14
Total number of patents in this class: 156
10-year publication summary
|
8
|
11
|
18
|
6
|
9
|
11
|
8
|
6
|
8
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ardelyx, Inc. | 119 |
9 |
| Novartis AG | 10251 |
6 |
| Merck Patent GmbH | 5729 |
6 |
| Omeros Corporation | 306 |
5 |
| Ferro Therapeutics, Inc. | 14 |
5 |
| Eli Lilly and Company | 4106 |
4 |
| Tongli Biomedical Co., Ltd | 31 |
4 |
| Bristol-myers Squibb Company | 4751 |
3 |
| The General Hospital Corporation | 4871 |
3 |
| Astellas Pharma Inc. | 1043 |
3 |
| Blueprint Medicines Corporation | 253 |
3 |
| Epiodyne, Inc. | 7 |
3 |
| LG Chem, Ltd. | 17929 |
2 |
| The Regents of the University of California | 20778 |
2 |
| Takeda Pharmaceutical Company Limited | 2710 |
2 |
| Arena Pharmaceuticals, Inc. | 344 |
2 |
| Daito Chemix Corporation | 12 |
2 |
| Enanta Pharmaceuticals, Inc. | 421 |
2 |
| Kanto Kagaku Kabushiki Kaisha | 92 |
2 |
| Les Laboratoires Servier | 498 |
2 |
| Other owners | 86 |